Rebalix
Logo AmundiAmundi · sheet of 10 September 2026
ETF sheet · official issuer and register data

Amundi MSCI World Ex EMU UCITS ETF Acc

CM9 · FR0010756114 · EUR · domicile France
Equity · GlobalSFDR art. 6
Index tracked: MSCI Daily Net TR World Ex EMU Euro
TER
0.35%+ trans. 0.00%
Fund size
979 m EUR
Tracking difference
−0.17%3-year avg
🇮🇹 tax rate
white list not published
Replication
Synthetic (swap)
Income
Mixed (acc. and/or dist.)
Launch 16 Jun 2009 · costs from the KID as of 2 Sept 2026 · 65 securities held · 10 venues (ESMA register)

The fund’s objective — in the issuer’s words

From the Key Information Document (KID) · 4 Aug 2026
By subscribing to Amundi MSCI World Ex EMU UCITS ETF (the "Fund"), you are investing in a passively managed UCITS whose objective is to replicate as closely as possible the performance of the MSCI World ex EMU index (the "Index") regardless of whether it experiences a positive or negative development. The maximum tracking error objective between the growth of the net asset value of the Fund and that of the Index is indicated in the Fund's prospectus. The Index, net dividends reinvested (dividends net of tax paid by the shares in the Index are included in…

Performance since series start (in euro) — base 100

10 Jul 20178 Sept 2026 · dividends reinvested where declared by the issuer
2018202020222024202630197296
High 301 (12 Aug 2026) · low 97 (7 Sept 2017) · last 296. Past performance is not indicative of future results.

Returns in euro

1 year+20.6%
3 years+60.8%
5 years+71.9%
10 yearsseries too young
Since series start+196.5%

Risk · 1 / 3 / 5 years

Volatility (ann.)10.80%13.36%14.55%
Max drawdown−6.54%−21.04%−21.04%
Sharpe1.551.000.64
Sortino2.241.400.89
Sharpe/Sortino: risk-free = ECB MRO avg; nominal volatility
Rebalix · CM9 · FR00107561141
RebalixCM9 · FR0010756114 · sheet of 10 September 2026

Tracking difference — year by year

Fund minus index, complete calendar years · declared by the issuer
YearFundIndexTD
2025+5.22%+5.37%−0.15%
2024+28.10%+28.26%−0.16%
2023+19.48%+19.67%−0.19%
2022−12.99%−12.81%−0.18%
2021+31.77%+32.04%−0.27%

Holdings

Synthetic replication: top positions of the substitute basket (swap collateral), not the fund’s exposure · 1 Sept 2026 · 65 securities · top-10 weight = 59.7%
Top holdingsWeight
NVIDIA CORP8.7%
AMAZON.COM INC8.4%
APPLE INC8.3%
TESLA INC8.1%
MICRON TECHNOLOGY INC5.1%
META PLATFORMS INC-CLASS A4.5%
MICROSOFT CORP4.4%
SCHWAB (CHARLES) CORP4.3%
COSTCO WHOLESALE CORP3.9%
AIRBNB INC-CLASS A3.9%

Listing venues

ESMA register (FIRDS) and official exchange lists
CM9 · Borsa Italiana (ETFplus), Euronext Paris
· Börse Düsseldorf, Börse Frankfurt, Börse Hamburg, Börse Hannover, Börse München / gettex, Börse Stuttgart, Tradegate Exchange
CM9GR · Xetra (Deutsche Börse)
+ 24 unmapped venues (MTF, RFQ, professional)

Official documents

Clickable links in the PDF
KID · www.amundietf.it/pdfDocuments/kid-priips/FR0010756114/ENG/NLD
Factsheet · www.amundietf.it/pdfDocuments/monthly-factsheet/FR0010756114/ENG/GBR/I
Prospectus · www.amundietf.it/pdfDocuments/prospectus/FR0010756114/ENG/GBR
The live sheet, always up to date
rebalix.com/en/etf/FR0010756114
Series, distributions, holdings and documents refresh daily.
Sheet produced on 10 September 2026 · data as of the dates shown section by section. Sources: official issuer documents (KID, factsheet, NAV series, declared portfolio), ESMA register (FIRDS), European Central Bank (FX), Italian tax authority / issuer (white-list share). Public methodology: rebalix.com/en/methodology. “—” = not published by the source, never estimated.

Informational document generated by rebalix.com: facts only, no recommendations. Not investment advice or investment research under Directive 2014/65/EU (MiFID II), nor an offer or solicitation. Past performance is not indicative of, nor a guarantee of, future results; the value of an investment can go down as well as up. Before any decision read the issuer’s KID and Prospectus; tax treatment depends on individual circumstances. Trademarks and logos belong to their respective owners and only identify the instrument and its issuer: no affiliation, sponsorship or endorsement.

Rebalix · CM9 · FR00107561142